Overview
Financials
Revenue history (in m)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 419 days for 2022). 2 of 6 audited by a statutory auditor.
- 202527/04/2026
- 202415/07/2025
- 202304/10/2024
- 202206/09/2024
- 202122/06/2022
- 202028/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Croma-pharma Gesellschaft M.b.h. | 69,130 | $933,684.49 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2013-06-07.
83 1030 1508 0000 0008 1688 3008
61 1030 1508 0000 0008 1688 3016
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 10, 2025 | Call to creditors |
Public aid
4 public aid cases recorded, with a total value of $569,921.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $14,798$14,798 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 24, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $522.4K$522,354 | Polski Fundusz Rozwoju S.A. | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $16,975$16,975 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| SPA Landsp. z o.o. | $4,782,973.66 | hydrafacial.pl | ||
| Hair Partnerssp. z o.o. | $4,347,484.74 | hairpartners.pl | ||
| Balmed Polandsp. z o.o. | $3,140,735.80 | balmed.it | ||
| Medikon Polskasp. z o.o. | $2,666,944.24 | medikon.pl | ||
| American Way Polska Miłkowskisp. k. | $1,893,749.17 | americanwaypolska.pl | ||
| Brandexsp. z o.o. | $1,958,619.75 | brandex.pl | ||
| PUBE Globalsp. z o.o. | $1,777,827.09 | pubeglobal.com | ||
| Tricopat Globalsp. z o.o. | $1,772,824.41 | tricopatglobal.com | ||
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-07 | Address change (Ul. Puławska 381, 02-801, Warszawa → Ul. Puławska 303, 02-785, Warszawa) | |
| 2026-04-01 | Share capital reduction (7,522,800.00 PLN → 3,456,500.00 PLN) | |
| 2016-04-26 | Share capital increase (7,500,000.00 PLN → 7,522,800.00 PLN) | |
| 2016-03-03 | PKD change (Removed: 21; Added: 20) | |
| 2015-11-12 | Address change (Ryżowa 31, 02-495, Warszawa → Ul. Puławska 381, 02-801, Warszawa) |
FAQ
Last updated: 2026-10-07